marketcaparena
Search

    XNCR

    Xencor Inc

    Company overview

    Market capitalization
    $1.90B
    Employees
    260
    Latest publication
    2026-09-29
    About Xencor Inc

    Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases. The company provides Ultomiris to treat patients with atypical hemolytic uremic syndrome, generalized myasthenia gravis, and neuromyelitis optica spectrum disororder; and Monjuvi for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma. It also develops XmAb819, a bispecific antibody to treat renal cell carcinoma; XmAb541, which is in Phase I for the treatment of ovarian cancer; XmAb808, a bispecific antibody that binds to the broadly expressed tumor antigen; XmAb942, which is in clinical development for patients with Crohn's disease and ulcerative colitis; Plamotamab, a bispecific T-cell, which is in Phase Ib study to treat rheumatoid arthritis; and XmAb657 for patients with idiopathic inflammatory myopathies. Further, the company develops Xaluritamig, a bispecific T-cell engager that treats prostate cancer; ASP2138 to treat gastric, gastroesophageal junction, and pancreatic cancers; JNJ-9401 to treat metastatic castration-resistant prostate cancer; Obexelimab, an antibody to treat patients with autoimmune diseases; Tobevibart, a treatment for chronic hepatitis Delta; Zaltenibart to treat paroxysmal nocturnal hemoglobinuria and other alternative pathway disorders; Teropavimab and zinlirvimab to treat human immunodeficiency virus; Novartis, an antibody drug candidate that uses XmAb Fc technologies; and JNJ-1493 to treat B-cell malignancies. The company was incorporated in 1997 and is headquartered in Pasadena, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20242024-12-31 · USDQ3 20192019-09-30 · USDQ2 20192019-06-30 · USDQ1 20192019-03-31 · USDQ4 20182018-12-31 · USDQ3 20182018-09-30 · USDQ2 20182018-06-30 · USD
    Total Revenue51,221,000USD70,018,000USD21,760,000USD19,485,000USD111,939,000USD11,564,000USD29,039,000USD0USD
    Research Development71,905,000USD51,056,000USD29,770,000USD33,299,000USD28,183,000USD27,130,000USD20,953,000USD23,332,000USD
    General And Administrative Expenses16,384,000USD———————
    Total Operating Expenses88,289,000USD65,971,000USD36,036,000USD39,057,000USD33,695,000USD32,647,000USD28,388,000USD28,290,000USD
    Operating Income-37,068,000USD4,047,000USD-14,276,000USD-19,572,000USD78,244,000USD-21,083,000USD651,000USD-28,290,000USD
    Total Other Income Expense Net15,149,000USD-56,673,000USD3,702,000USD3,588,000USD2,701,000USD2,884,000USD2,499,000USD2,421,000USD
    Interest Income4,800,000USD8,164,000USD3,699,000USD3,615,000USD2,886,000USD———
    Interest Expense7,352,000USD33,927,000USD3,699,000USD3,615,000USD2,886,000USD16,000USD2,642,000USD3,000USD
    Income Before Tax-21,919,000USD-52,626,000USD-10,574,000USD-15,984,000USD80,945,000USD-18,199,000USD3,150,000USD-25,869,000USD
    Income Tax Expense-190,000USD1,500,000USD-350,000USD50,000USD900,000USD-883,000USD-816,000USD-822,000USD
    Net Income-21,729,000USD-53,479,000USD-10,224,000USD-16,034,000USD80,045,000USD-18,199,000USD3,150,000USD-25,869,000USD
    Minority Interest0USD647,000USD———0USD0USD0USD
    Cost Of Revenue—51,056,000USD29,770,000USD33,299,000USD28,183,000USD27,130,000USD20,953,000USD23,332,000USD
    Gross Profit—70,018,000USD-8,010,000USD-13,814,000USD83,756,000USD-15,566,000USD8,086,000USD-23,332,000USD
    Selling General Administrative—14,915,000USD6,266,000USD5,758,000USD5,512,000USD5,517,000USD7,435,000USD4,958,000USD
    Net Interest Income—-25,763,000USD3,699,000USD3,615,000USD2,886,000USD———
    Tax Provision—1,500,000USD-350,000USD50,000USD900,000USD———
    Net Income From Continuing Ops—-54,126,000USD-10,224,000USD-16,034,000USD80,045,000USD-18,197,000USD3,150,000USD-25,869,000USD
    Ebit—-18,699,000USD-14,276,000USD-19,572,000USD80,945,000USD-18,199,000USD651,000USD-28,290,000USD
    Ebitda—-15,705,000USD-13,206,000USD-18,565,000USD81,941,000USD-17,316,000USD1,467,000USD-27,468,000USD
    Depreciation And Amortization—2,994,000USD1,070,000USD1,007,000USD996,000USD883,000USD816,000USD822,000USD
    Reconciled Depreciation—2,994,000USD1,070,000USD1,007,000USD996,000USD883,000USD816,000USD822,000USD
    Non Operating Income Net Other——-190,000USD1,257,000USD1,131,000USD6,903,000USD-473,000USD2,617,000USD
    Net Income Applicable To Common Shares——-10,224,000USD-16,034,000USD80,045,000USD-18,197,000USD3,150,000USD-25,869,000USD
    Discontinued Operations—————0USD0USD0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USD
    Total Revenue168,338,000USD164,579,000USD122,694,000USD156,700,000USD35,711,000USD87,520,000USD9,520,000USD10,172,000USD
    Cost Of Revenue253,598,000USD8,799,000USD169,802,000USD118,590,000USD71,772,000USD51,872,000USD18,516,000USD17,000,000USD
    Gross Profit-85,260,000USD164,579,000USD122,694,000USD38,110,000USD35,711,000USD87,520,000USD-8,996,000USD-6,828,000USD
    Research Development253,598,000USD199,563,000USD169,802,000USD118,590,000USD71,772,000USD51,872,000USD18,516,000USD17,000,000USD
    Selling General Administrative53,379,000USD47,489,000USD29,689,000USD24,286,000USD17,501,000USD13,108,000USD7,461,000USD3,692,000USD
    Total Operating Expenses306,977,000USD247,052,000USD199,491,000USD24,286,000USD89,273,000USD64,980,000USD25,977,000USD20,692,000USD
    Operating Income-138,639,000USD-82,473,000USD-76,797,000USD13,824,000USD-53,562,000USD22,540,000USD-16,457,000USD-10,520,000USD
    Interest Income13,740,000USD4,817,000USD7,264,000USD13,619,000USD4,194,000USD2,091,000USD——
    Interest Expense6,177,000USD36,764,000USD0USD17,661,000USD13,000USD21,000USD9,000USD1,213,000USD
    Net Interest Income13,740,000USD4,817,000USD7,264,000USD13,619,000USD4,181,000USD2,070,000USD——
    Income Before Tax-120,439,000USD-54,508,000USD-69,333,000USD27,187,000USD-49,388,000USD24,616,000USD-16,422,000USD-60,258,000USD
    Income Tax Expense5,811,000USD673,000USD-5,794,000USD312,000USD-463,000USD991,000USD-829,000USD533,000USD
    Tax Provision-415,000USD673,000USD-288,000USD312,000USD-463,000USD991,000USD——
    Net Income-126,087,000USD-55,181,000USD-63,539,000USD26,875,000USD-48,925,000USD23,625,000USD-16,422,000USD-60,258,000USD
    Net Income From Continuing Ops-119,028,000USD-55,181,000USD-69,333,000USD26,875,000USD-48,925,000USD23,625,000USD-16,422,000USD—
    Ebit-137,372,000USD-82,473,000USD-76,797,000USD13,824,000USD-53,562,000USD22,540,000USD-16,413,000USD-59,046,000USD
    Ebitda-125,874,000USD-73,674,000USD-71,003,000USD18,122,000USD-51,532,000USD24,006,000USD-15,531,000USD-58,335,000USD
    Depreciation And Amortization11,498,000USD8,799,000USD5,794,000USD4,298,000USD2,030,000USD1,466,000USD882,000USD711,000USD
    Reconciled Depreciation10,429,000USD8,799,000USD5,794,000USD4,298,000USD2,030,000USD———
    Total Other Income Expense Net18,200,000USD27,965,000USD7,464,000USD13,363,000USD4,174,000USD2,076,000USD35,000USD-49,739,000USD
    Minority Interest163,000USD0USD——————
    Net Income Applicable To Common Shares—-55,181,000USD-69,333,000USD26,875,000USD-48,925,000USD23,625,000USD-16,422,000USD—
    Non Operating Income Net Other——-887,000USD1,876,000USD3,820,000USD1,172,000USD44,000USD—
    Unclassified Operating Expenses———-118,590,000USD————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets724,960,000USD736,846,000USD875,495,000USD868,811,000USD879,424,000USD904,689,000USD951,945,000USD983,635,000USD
    Cash And Equivalents44,663,000USD———————
    Total Current Assets523,213,000USD482,855,000USD599,821,000USD518,441,000USD513,150,000USD521,271,000USD577,601,000USD573,328,000USD
    Other Current Assets24,527,000USD25,904,000USD22,789,000USD25,592,000USD21,732,000USD13,920,000USD18,977,000USD20,146,000USD
    Other Non Current Assets498,000USD———————
    Total Liabilities221,732,000USD———————
    Total Current Liabilities81,865,000USD73,457,000USD95,907,000USD86,485,000USD96,083,000USD88,436,000USD87,432,000USD91,972,000USD
    Other Current Liabilities36,446,000USD———————
    Other Non Current Liabilities152,000USD———————
    Total Stockholder Equity503,228,000USD515,633,000USD635,587,000USD625,316,000USD620,351,000USD639,874,000USD677,611,000USD723,836,000USD
    Total Equity Including Noncontrolling Interest503,228,000USD———————
    Long Term Debt77,537,000USD82,124,000USD76,482,000USD———115,159,000USD10,169,000USD
    Net Receivables42,234,000USD12,001,000USD29,299,000USD21,805,000USD47,554,000USD37,785,000USD60,849,000USD10,205,000USD
    Property Plant Equipment Net85,999,000USD88,307,000USD90,900,000USD92,958,000USD93,839,000USD96,458,000USD98,141,000USD101,231,000USD
    Intangible Assets6,524,000USD7,602,000USD8,385,000USD9,468,000USD11,252,000USD13,363,000USD18,485,000USD17,919,000USD
    Accounts Payable12,648,000USD7,919,000USD10,828,000USD9,079,000USD18,533,000USD16,191,000USD16,759,000USD18,770,000USD
    Short Term Debt27,358,000USD30,444,000USD46,530,000USD49,298,000USD3,380,000USD3,640,000USD51,456,000USD9,930,000USD
    Common Stock744,000USD741,000USD718,000USD714,000USD714,000USD712,000USD703,000USD701,000USD
    Retained Earnings-946,604,000USD-924,875,000USD-795,959,000USD-789,306,000USD-783,279,000USD-752,454,000USD-704,036,000USD-643,511,000USD
    Accumulated Other Comprehensive Income-872,000USD27,000USD1,576,000USD1,158,000USD258,000USD355,000USD-663,000USD1,800,000USD
    Total Liab—221,213,000USD239,908,000USD243,495,000USD259,073,000USD264,815,000USD277,919,000USD262,737,000USD
    Other Current Liab—34,253,000USD34,960,000USD28,108,000USD74,170,000USD68,605,000USD19,217,000USD25,407,000USD
    Capital Stock—741,000USD718,000USD714,000USD714,000USD712,000USD703,000USD701,000USD
    Cash—14,170,000USD54,073,000USD28,291,000USD44,442,000USD39,675,000USD40,875,000USD29,031,000USD
    Cash And Short Term Investments—444,950,000USD547,733,000USD471,044,000USD443,864,000USD469,566,000USD497,775,000USD542,977,000USD
    Net Debt—160,994,000USD133,674,000USD174,114,000USD23,489,000USD28,149,000USD191,078,000USD57,557,000USD
    Short Long Term Debt—26,410,000USD43,267,000USD———48,447,000USD7,749,000USD
    Short Long Term Debt Total—175,164,000USD187,747,000USD202,405,000USD67,931,000USD67,824,000USD231,953,000USD86,588,000USD
    Long Term Investments—157,393,000USD175,602,000USD247,158,000USD260,399,000USD272,815,000USD256,833,000USD290,274,000USD
    Short Term Investments—430,780,000USD493,660,000USD442,753,000USD399,422,000USD429,891,000USD456,900,000USD513,946,000USD
    Property Plant Equipment Gross—142,135,000USD142,372,000USD142,359,000USD140,853,000USD141,073,000USD140,320,000USD101,231,000USD
    Common Stock Shares Outstanding—75,247,000shares74,239,000shares74,413,000shares74,279,000shares73,667,000shares73,176,000shares64,023,000shares
    Non Current Assets Total—253,991,000USD275,674,000USD350,370,000USD366,274,000USD383,418,000USD374,344,000USD410,307,000USD
    Non Current Liabilities Total—147,756,000USD144,001,000USD157,010,000USD162,990,000USD176,379,000USD190,487,000USD170,765,000USD
    Non Current Liabilities Other—152,000USD—87,776,000USD94,736,000USD101,837,000USD——
    Non Currrent Assets Other—498,000USD498,000USD498,000USD784,000USD782,000USD885,000USD883,000USD
    Net Working Capital—409,398,000USD503,914,000USD431,956,000USD417,067,000USD432,835,000USD490,169,000USD481,356,000USD
    Unclassified Current Liabilities—-25,569,000USD-39,678,000USD———-86,312,000USD-7,749,000USD
    Unclassified Non Current Liabilities—65,480,000USD67,519,000USD69,234,000USD68,254,000USD74,542,000USD75,328,000USD160,596,000USD
    Unclassified Equity—1,438,999,000USD1,428,534,000USD1,412,036,000USD1,401,944,000USD1,390,549,000USD1,380,904,000USD1,364,145,000USD
    Current Deferred Revenue——————37,865,000USD37,865,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets875,495,000USD951,945,000USD952,692,000USD846,266,000USD838,211,000USD703,244,000USD670,250,000USD576,732,000USD
    Intangible Assets8,385,000USD18,485,000USD18,663,000USD18,500,000USD16,493,000USD15,977,000USD14,421,000USD11,969,000USD
    Other Current Assets22,789,000USD18,977,000USD18,145,000USD23,283,000USD23,877,000USD10,726,000USD6,547,000USD11,179,000USD
    Total Liab239,908,000USD277,919,000USD283,559,000USD118,770,000USD104,707,000USD130,800,000USD77,049,000USD55,051,000USD
    Total Stockholder Equity635,587,000USD677,611,000USD669,133,000USD727,496,000USD733,504,000USD572,444,000USD593,201,000USD521,681,000USD
    Other Current Liab34,960,000USD9,227,000USD23,564,000USD18,728,000USD19,443,000USD17,603,000USD8,995,000USD9,977,000USD
    Common Stock718,000USD703,000USD611,000USD601,000USD595,000USD580,000USD569,000USD563,000USD
    Capital Stock718,000USD703,000USD611,000USD601,000USD595,000USD580,000USD569,000USD563,000USD
    Retained Earnings-795,959,000USD-704,036,000USD-464,372,000USD-338,285,000USD-283,104,000USD-365,735,000USD-296,402,000USD-323,277,000USD
    Cash54,073,000USD40,875,000USD53,790,000USD53,942,000USD143,480,000USD163,544,000USD50,312,000USD26,246,000USD
    Cash And Short Term Investments547,733,000USD497,775,000USD593,725,000USD623,062,000USD334,107,000USD603,003,000USD527,082,000USD294,361,000USD
    Total Current Assets599,821,000USD577,601,000USD623,160,000USD675,342,000USD424,368,000USD637,672,000USD558,405,000USD315,727,000USD
    Total Current Liabilities95,907,000USD87,432,000USD84,709,000USD63,844,000USD70,738,000USD121,061,000USD66,558,000USD53,853,000USD
    Net Debt133,674,000USD191,078,000USD29,644,000USD5,692,000USD-109,511,000USD-151,916,000USD-39,578,000USD-26,246,000USD
    Short Term Debt46,530,000USD51,456,000USD9,767,000USD4,708,000USD33,969,000USD1,889,000USD2,169,000USD9,662,000USD
    Short Long Term Debt43,267,000USD48,447,000USD6,332,000USD—————
    Short Long Term Debt Total187,747,000USD231,953,000USD83,434,000USD59,634,000USD33,969,000USD11,628,000USD10,734,000USD—
    Long Term Debt76,482,000USD115,159,000USD14,642,000USD—————
    Long Term Investments175,602,000USD256,833,000USD209,722,000USD58,209,000USD331,727,000USD17,101,000USD71,928,000USD236,912,000USD
    Short Term Investments493,660,000USD456,900,000USD539,935,000USD569,120,000USD190,627,000USD439,459,000USD476,770,000USD268,115,000USD
    Net Receivables29,299,000USD60,849,000USD11,290,000USD28,997,000USD66,384,000USD23,943,000USD24,776,000USD10,187,000USD
    Accounts Payable10,828,000USD16,759,000USD13,914,000USD10,088,000USD14,001,000USD8,954,000USD10,189,000USD3,797,000USD
    Property Plant Equipment Net90,900,000USD98,141,000USD100,119,000USD93,602,000USD59,970,000USD32,282,000USD25,185,000USD11,813,000USD
    Property Plant Equipment Gross142,372,000USD140,320,000USD136,345,000USD93,602,000USD59,970,000USD21,682,000USD25,185,000USD11,813,000USD
    Accumulated Other Comprehensive Income1,576,000USD-663,000USD1,291,000USD-6,952,000USD-1,510,000USD74,000USD1,161,000USD-971,000USD
    Common Stock Shares Outstanding74,239,000shares65,041,000shares60,503,283shares59,652,461shares60,495,455shares57,212,737shares58,467,880shares53,942,116shares
    Non Current Assets Total275,674,000USD374,344,000USD329,532,000USD170,924,000USD413,843,000USD65,572,000USD111,845,000USD261,005,000USD
    Non Current Liabilities Total144,001,000USD190,487,000USD198,850,000USD54,926,000USD33,969,000USD9,739,000USD10,491,000USD1,198,000USD
    Non Currrent Assets Other498,000USD885,000USD1,028,000USD613,000USD653,000USD212,000USD713,000USD311,000USD
    Net Working Capital503,914,000USD490,169,000USD538,451,000USD611,498,000USD353,630,000USD516,611,000USD491,847,000USD261,874,000USD
    Unclassified Current Liabilities-39,678,000USD-70,139,000USD——-33,969,000USD——-9,662,000USD
    Unclassified Non Current Liabilities67,519,000USD75,328,000USD184,208,000USD54,926,000USD——-1,926,000USD-1,198,000USD
    Unclassified Equity1,428,534,000USD1,380,904,000USD1,130,992,000USD1,071,531,000USD1,016,928,000USD936,945,000USD887,304,000USD844,803,000USD
    Current Deferred Revenue—31,682,000USD31,682,000USD30,320,000USD37,294,000USD92,615,000USD45,205,000USD40,079,000USD
    Inventory——-11,290,000USD1USD-36,860,000USD—1USD1USD
    Other Assets———613,000USD5,653,000USD212,000USD713,000USD1,115,000USD
    Net Tangible Assets———708,996,000USD717,011,000USD556,467,000USD578,780,000USD509,712,000USD
    Non Current Liabilities Other————33,969,000USD9,739,000USD10,491,000USD—
    Other Liab——————1,926,000USD1,198,000USD
    Deferred Long Term Liab———————1,198,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-128,916,000USD85,484,000USD-6,027,000USD-30,825,000USD-48,418,000USD-54,126,000USD-48,418,000USD-68,782,000USD
    Depreciation2,567,000USD2,577,000USD2,589,000USD2,653,000USD2,693,000USD2,994,000USD3,054,000USD3,024,000USD
    Stock Based Compensation9,561,000USD10,185,000USD10,092,000USD10,737,000USD12,213,000USD12,332,000USD12,338,000USD17,190,000USD
    Other Non Cash Items52,085,000USD-158,087,000USD-57,622,000USD-12,829,000USD4,229,000USD-2,874,000USD-17,004,000USD855,000USD
    Change To Account Receivables5,800,000USD-5,798,000USD19,896,000USD-8,769,000USD23,405,000USD-34,068,000USD11,868,000USD-12,969,000USD
    Change In Working Capital-2,925,000USD8,130,000USD20,151,000USD-6,105,000USD25,276,000USD-13,901,000USD24,012,000USD-19,637,000USD
    Total Cash From Operating Activities-67,628,000USD-51,711,000USD-30,817,000USD-36,369,000USD-16,219,999USD-55,575,000USD-26,018,000USD-67,350,000USD
    Capital Expenditures-610,000USD-1,140,000USD-183,000USD-383,000USD-1,444,000USD-2,683,000USD-2,122,000USD-3,646,000USD
    Free Cash Flow-68,238,000USD-52,851,000USD-31,000,000USD-36,752,000USD-17,664,000USD-58,258,000USD-28,140,000USD-70,996,000USD
    Investments27,287,000USD72,313,000USD14,668,000USD40,476,000USD13,668,000USD57,252,000USD-163,458,000USD66,016,000USD
    Total Cashflows From Investing Activities26,677,000USD71,173,000USD14,668,000USD40,476,000USD11,943,000USD57,252,000USD-163,458,000USD66,016,000USD
    Total Cash From Financing Activities950,000USD6,321,000USD0USD662,000USD2,974,000USD10,169,000USD187,740,000USD1,070,000USD
    Change In Cash-39,903,000USD25,783,000USD-16,149,000USD4,769,000USD-1,200,000USD11,846,000USD-1,736,000USD-264,000USD
    Begin Period Cash Flow54,073,000USD28,579,000USD44,728,000USD39,959,000USD40,875,000USD29,416,000USD31,152,000USD31,416,000USD
    End Period Cash Flow14,170,000USD54,362,000USD28,579,000USD44,728,000USD39,675,000USD41,262,000USD29,416,000USD31,152,000USD
    Other Cashflows From Financing Activities950,000USD6,321,000USD——-1,725,000USD10,169,000USD-2,124,000USD1,070,000USD
    Sale Purchase Of Stock—-34,000USD662,000USD662,000USD—930,000USD930,000USD—
    Issuance Of Capital Stock—0USD———0USD——
    Other Cashflows From Investing Activities—7,690,000USD-407,000USD5,380,000USD—-1,019,000USD-2,396,000USD-620,000USD
    Unclassified Investing Cash Flow—-7,690,000USD—-4,997,000USD—3,702,000USD4,518,000USD4,266,000USD
    Unclassified Operating Cash Flow————-12,212,999USD———
    Unclassified Financing Cash Flow————4,699,000USD—188,934,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Net Income-91,923,000USD-236,540,000USD-126,087,000USD-55,181,000USD82,631,000USD26,875,000USD-70,409,000USD-48,925,000USD
    Depreciation10,512,000USD12,107,000USD11,498,000USD8,799,000USD7,491,000USD4,298,000USD3,251,000USD2,030,000USD
    Stock Based Compensation43,227,000USD53,281,000USD53,755,000USD48,913,000USD36,975,000USD31,851,000USD20,548,000USD13,651,000USD
    Other Non Cash Items-144,385,000USD9,364,000USD-20,076,000USD-26,911,000USD-22,379,000USD-4,092,000USD21,000USD3,324,000USD
    Change To Account Receivables28,734,000USD-32,673,000USD17,707,000USD36,857,000USD-54,941,000USD-11,004,000USD-9,045,000USD7,474,000USD
    Change In Working Capital47,452,000USD-40,400,000USD166,021,000USD48,865,000USD-102,601,000USD5,442,000USD-33,167,000USD-3,763,000USD
    Total Cash From Operating Activities-135,117,000USD-202,188,000USD85,111,000USD24,485,000USD-16,853,000USD64,374,000USD-79,756,000USD-33,683,000USD
    Capital Expenditures-3,150,000USD-6,097,000USD-21,251,000USD-43,404,000USD-15,981,000USD-11,038,000USD-9,147,000USD-7,278,000USD
    Free Cash Flow-138,267,000USD-208,285,000USD63,860,000USD-18,919,000USD-32,834,000USD53,336,000USD-88,903,000USD-40,961,000USD
    Investments143,135,000USD-7,872,000USD116,613,000USD-119,725,000USD-29,445,000USD-39,932,000USD-155,629,000USD39,228,000USD
    Total Cashflows From Investing Activities139,985,000USD-7,872,000USD—-119,725,000USD-46,249,000USD-50,970,000USD-164,767,000USD31,950,000USD
    Total Cash From Financing Activities8,232,000USD197,152,000USD26,182,000USD5,702,000USD43,038,000USD10,662,000USD254,241,000USD3,733,000USD
    Sale Purchase Of Stock1,290,000USD1,977,000USD1,977,000USD2,092,000USD1,837,000USD1,393,000USD936,000USD3,733,000USD
    Issuance Of Capital Stock0USD201,256,000USD0USD0USD28,920,000USD0USD260,245,000USD—
    Change In Cash13,100,000USD-12,908,000USD228,000USD-89,538,000USD-20,064,000USD24,066,000USD9,718,000USD2,000,000USD
    Begin Period Cash Flow41,262,000USD54,170,000USD53,942,000USD143,480,000USD163,544,000USD26,246,000USD16,528,000USD14,528,000USD
    End Period Cash Flow54,362,000USD41,262,000USD54,170,000USD53,942,000USD143,480,000USD50,312,000USD26,246,000USD16,528,000USD
    Other Cashflows From Investing Activities14,388,000USD-3,378,000USD-2,802,000USD90,000USD-3,160,000USD-3,685,000USD2,021,000USD33,917,000USD
    Other Cashflows From Financing Activities-1,725,000USD-4,104,000USD26,182,000USD5,702,000USD14,118,000USD10,662,000USD-6,004,000USD3,733,000USD
    Unclassified Investing Cash Flow-14,388,000USD9,475,000USD—43,314,000USD2,337,000USD3,685,000USD-2,012,000USD-33,917,000USD
    Unclassified Financing Cash Flow8,667,000USD199,279,000USD-1,977,000USD-2,092,000USD27,083,000USD-1,393,000USD259,309,000USD-3,733,000USD
    Change To Liabilities———-10,887,000USD6,887,000USD5,725,000USD953,000USD-7,143,000USD
    Change To Inventory————1,403,000USD3,478,000USD-1,363,000USD-5,643,000USD
    Cash And Cash Equivalents Changes————-20,064,000USD24,066,000USD9,718,000USD2,000,000USD
    Unclassified Operating Cash Flow————-18,970,000USD———
    Dividends Paid———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductLicense0USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductMilestone10,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductRoyalty41,221,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductLicense100,000USD0001326732-26-000043
    Q1 2026Quarterly · 2026-03-31ProductMilestone0USD0001326732-26-000043
    Q1 2026Quarterly · 2026-03-31ProductRoyalty4,416,000USD0001326732-26-000043
    Q4 2025Quarterly · 2025-12-31ProductLicense0USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductMilestone5,800,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductRoyalty22,437,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductCollaboration0USD0001326732-26-000015
    FY 2025Yearly · 2025-12-31ProductLicense0USD0001326732-26-000015
    FY 2025Yearly · 2025-12-31ProductMilestone45,300,000USD0001326732-26-000015
    FY 2025Yearly · 2025-12-31ProductRoyalty80,276,000USD0001326732-26-000015
    Q3 2025Quarterly · 2025-09-30ProductLicense0USD0001326732-25-000087
    Q3 2025Quarterly · 2025-09-30ProductMilestone0USD0001326732-25-000087
    Q3 2025Quarterly · 2025-09-30ProductRoyalty20,999,000USD0001326732-25-000087
    Q2 2025Quarterly · 2025-06-30ProductLicense0USD0001326732-25-000075
    Q2 2025Quarterly · 2025-06-30ProductMilestone25,000,000USD0001326732-25-000075
    Q2 2025Quarterly · 2025-06-30ProductRoyalty18,608,000USD0001326732-25-000075
    Q1 2025Quarterly · 2025-03-31ProductLicense0USD0001326732-26-000043
    Q1 2025Quarterly · 2025-03-31ProductMilestone14,500,000USD0001326732-26-000043
    Q1 2025Quarterly · 2025-03-31ProductRoyalty18,232,000USD0001326732-26-000043
    FY 2024Yearly · 2024-12-31ProductCollaboration0USD0001326732-25-000029
    FY 2024Yearly · 2024-12-31ProductLicense8,500,000USD0001326732-25-000029
    FY 2024Yearly · 2024-12-31ProductMilestone34,500,000USD0001326732-25-000029
    FY 2024Yearly · 2024-12-31ProductNon Cash Royalties66,900,000USD0001326732-25-000029
    FY 2024Yearly · 2024-12-31ProductRoyalty600,000USD0001326732-25-000029
    Q3 2024Quarterly · 2024-09-30ProductLicense0USD0001326732-25-000087
    Q3 2024Quarterly · 2024-09-30ProductMilestone0USD0001326732-25-000087
    Q3 2024Quarterly · 2024-09-30ProductRoyalty17,796,000USD0001326732-25-000087
    Q2 2024Quarterly · 2024-06-30ProductLicense8,500,000USD0001326732-25-000075
    Q2 2024Quarterly · 2024-06-30ProductMilestone0USD0001326732-25-000075
    Q2 2024Quarterly · 2024-06-30ProductRoyalty15,407,000USD0001326732-25-000075
    FY 2023Yearly · 2023-12-31ProductCollaboration30,300,000USD0001326732-25-000029
    FY 2023Yearly · 2023-12-31ProductLicense0USD0001326732-25-000029
    FY 2023Yearly · 2023-12-31ProductMilestone88,500,000USD0001326732-25-000029
    FY 2023Yearly · 2023-12-31ProductNon Cash Royalties14,600,000USD0001326732-25-000029
    FY 2023Yearly · 2023-12-31ProductRoyalty41,200,000USD0001326732-25-000029
    FY 2022Yearly · 2022-12-31ProductCollaboration7,000,000USD0001326732-25-000029
    FY 2022Yearly · 2022-12-31ProductLicense0USD0001326732-25-000029
    FY 2022Yearly · 2022-12-31ProductMilestone5,500,000USD0001326732-25-000029
    FY 2022Yearly · 2022-12-31ProductNon Cash Royalties0USD0001326732-25-000029
    FY 2022Yearly · 2022-12-31ProductRoyalty152,100,000USD0001326732-25-000029
    FY 2021Yearly · 2021-12-31ProductCollaboration93,000,000USD0001326732-24-000006
    FY 2021Yearly · 2021-12-31ProductLicense80,800,000USD0001326732-24-000006
    FY 2021Yearly · 2021-12-31ProductMilestone21,000,000USD0001326732-24-000006
    FY 2021Yearly · 2021-12-31ProductRoyalty80,300,000USD0001326732-24-000006
    FY 2020Yearly · 2020-12-31ProductCollaboration4,500,000USD0001628280-23-005127
    FY 2020Yearly · 2020-12-31ProductLicense50,200,000USD0001628280-23-005127
    FY 2020Yearly · 2020-12-31ProductMilestone50,200,000USD0001628280-23-005127
    FY 2020Yearly · 2020-12-31ProductRoyalty17,800,000USD0001628280-23-005127
    FY 2020Yearly · 2020-12-31GeographyNon United States58,600,000USD0001558370-21-001522
    FY 2020Yearly · 2020-12-31GeographyUnited States64,100,000USD0001558370-21-001522
    FY 2019Yearly · 2019-12-31ProductCollaboration16,300,000USD0001558370-22-001969
    FY 2019Yearly · 2019-12-31ProductLicense112,200,000USD0001558370-22-001969
    FY 2019Yearly · 2019-12-31ProductMilestone23,200,000USD0001558370-22-001969
    FY 2019Yearly · 2019-12-31ProductRoyalty5,000,000USD0001558370-22-001969
    FY 2019Yearly · 2019-12-31GeographyNon United States14,000,000USD0001558370-21-001522
    FY 2019Yearly · 2019-12-31GeographyUnited States142,700,000USD0001558370-21-001522
    FY 2018Yearly · 2018-12-31ProductCollaboration20,100,000USD0001558370-21-001522
    FY 2018Yearly · 2018-12-31ProductMilestone20,500,000USD0001558370-21-001522
    FY 2017Yearly · 2017-12-31GeographyNon United States16,000,000USD0001558370-20-001256
    FY 2017Yearly · 2017-12-31GeographyUnited States30,200,000USD0001558370-20-001256

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.